Skip to content
Sunday, 22 November 2026
Markets

Singapore’s IPO Revival Faces Investor Confidence Test as New Listings Struggle to Deliver Returns

Singapore Exchange is attracting new IPOs after major market reforms, but weak aftermarket performance raises questions about valuations, liquidity and investor confidence.

By The Ledger Asia16 min read
Singapore’s IPO Revival Faces Investor Confidence Test | The Ledger Asia
The Ledger Asia · Capital Markets · SGX

Singapore’s IPO Revival Faces Investor Confidence Test as New Listings Struggle to Deliver Returns

SGX is attracting renewed listing interest following government-backed market reforms, but the performance of newly listed shares suggests that improving market activity is only the first step towards restoring investor confidence.

SGX IPOs8January–September 2026, EY figures reported by CNA
Capital raisedUS$1.28bnJanuary–September 2026
Proceeds change−16.9%Calculated from rounded US$1.54bn in Jan–Sep 2025
Below offer8 of 10Separate 8 November commentary snapshot

SINGAPORE, 22 November 2026 — Singapore’s initial public offering market is showing signs of recovery after several difficult years, but the return of new listings has exposed a familiar challenge: attracting companies to the stock exchange does not necessarily guarantee attractive investment returns.

Singapore Exchange (SGX) recorded eight IPOs during the first nine months of 2026, raising approximately US$1.28 billion, according to figures from Ernst & Young (EY) reported by Channel NewsAsia.

The number of listings increased from seven during the corresponding period in 2025, but the amount raised declined from US$1.54 billion. The figures suggest that Singapore’s IPO recovery has been uneven, with modest growth in listing numbers accompanied by a reduction in total fundraising.

More importantly, concerns have emerged about the performance of companies after their shares begin trading.

A November market commentary published by Lianhe Zaobao reported that eight of ten IPOs assessed were trading below their offer prices, with some recording declines exceeding 50%.

The finding raises questions about valuation discipline, investor expectations and the effectiveness of efforts to strengthen Singapore’s equity market. However, the ten-listing assessment and EY’s January-to-September figures represent different reporting periods and should not be treated as identical datasets.

The broader question for Singapore is whether its capital-market reforms can generate not only more listings, but also stronger liquidity, sustainable company performance and lasting investor confidence.

Singapore’s IPO Market Shows Signs of Recovery

Singapore has spent several years attempting to revitalise its stock exchange.

The city-state remains an important international financial centre, but its equity market has faced challenges in attracting new companies, particularly high-growth technology businesses.

In 2024, SGX recorded only four IPOs, its lowest annual total in more than a decade, according to market figures cited by Channel NewsAsia. The limited pipeline raised concerns about the exchange’s ability to compete for listings against larger regional markets.

Hong Kong benefits from its role as an international fundraising centre for mainland Chinese companies. Malaysia has a substantial domestic pipeline of small and medium-sized enterprises seeking access to public capital.

Singapore operates within a different corporate and investment environment. Its domestic business base is smaller, while its stock market has traditionally been associated with banks, real estate investment trusts and established income-generating companies.

These structural differences make comparisons based solely on IPO numbers potentially misleading.

Nevertheless, Singapore’s eight listings during the first nine months of 2026 represent an improvement from the corresponding period a year earlier. The recovery also follows a series of regulatory and market-development measures introduced by the Monetary Authority of Singapore (MAS), SGX and other industry participants.

Eight IPOs Raise US$1.28 Billion

Singapore’s eight IPOs raised approximately US$1.28 billion between January and September 2026. This compared with US$1.54 billion from seven listings during the same period in 2025.

The reduction in proceeds amounted to approximately US$260 million, or 16.9%, based on the rounded figures reported by EY.

The decline illustrates an important distinction between listing activity and fundraising value. An exchange can attract more companies while raising less capital if the average size of its offerings decreases. Conversely, a small number of large IPOs can generate substantial proceeds even when listing volume remains limited.

Singapore’s market has historically been influenced by this relationship. Large real estate investment trust offerings and other institutional transactions can account for a significant proportion of annual fundraising.

For investors, however, the amount raised by an issuer does not establish whether its shares represent an attractive investment. The offering price, financial outlook and subsequent trading performance remain important considerations.

IPO listings by market

January–September 2026 · count

Singapore and Malaysia IPO listingsMalaysia recorded 38 IPO listings and Singapore recorded 8 during January to September 2026. 010203040 8Singapore38Malaysia
IPO proceeds by market

January–September 2026 · US$ billion

Singapore and Malaysia IPO proceedsMalaysia raised 1.62 billion US dollars and Singapore raised 1.28 billion US dollars during January to September 2026. 00.51.01.52.0 US$1.28bnSingaporeUS$1.62bnMalaysia

Singapore Raises Substantial Capital From Fewer Listings

The contrast with Malaysia is particularly revealing. During the first nine months of 2026, Malaysia recorded 38 IPOs and raised US$1.62 billion. Singapore recorded eight listings and raised US$1.28 billion.

Malaysia therefore attracted almost five times as many listings, but its total proceeds were only about 27% higher.

Based on these aggregate figures, Singapore raised approximately US$160 million per IPO, compared with around US$42.6 million in Malaysia. These are simple averages calculated from total proceeds divided by listing count.

They do not describe the typical or median IPO size, and individual large transactions can substantially influence the results. Nevertheless, the figures demonstrate that Singapore’s smaller IPO pipeline can still generate considerable fundraising activity.

The distinction is important when assessing the competitiveness of regional exchanges. Malaysia’s strength lies partly in its broad pipeline of smaller growth companies. Singapore’s market may be better positioned to attract selected larger issuers, international businesses and companies seeking access to its institutional investment ecosystem.

Neither approach automatically guarantees superior shareholder returns.

Singapore–Malaysia IPO comparison
MeasureSingaporeMalaysiaPeriod / qualification
IPO listings838January–September 2026; EY figures reported by CNA
IPO proceedsUS$1.28bnUS$1.62bnJanuary–September 2026
Simple proceeds per listingApprox. US$160mApprox. US$42.6mArithmetic averages; not medians and sensitive to large deals
Below-offer snapshot8 of 1054% of 46Different samples and dates: Singapore commentary published 8 Nov; Malaysia sample assessed 4 Nov
What the snapshot meansShare of companies below their offer prices, not the average loss, a capital-weighted return or total investor wealth lostPoint-in-time market observations; prices can change
Do not combine the samples. The Singapore “8 of 10” statistic is from a November Lianhe Zaobao commentary. Malaysia’s “54% of 46” is a separate 4 November snapshot cited by Channel NewsAsia. Neither is a direct subset of the January–September regional listing dataset, and they are not measured on an identical date or denominator.
Singapore post-listing snapshot

November commentary · 10 IPOs assessed

Singapore IPOs below offer priceEight of ten IPOs in a November commentary were trading below their offer prices. Two were not reported as below offer.8 below offer280% of the 10-company commentary sample
Malaysia post-listing snapshot

4 November 2026 · 46 Main/ACE IPOs assessed

Malaysian IPOs below offer priceFifty-four percent of a 46-company Malaysian IPO sample was below offer price and 46 percent was above.54% below46% abovePercentages reported; exact counts are not inferred

The Bigger Concern: Newly Listed Shares Trading Below Offer Prices

The recovery in IPO activity has not eliminated concerns about aftermarket performance.

A November commentary in Lianhe Zaobao reported that eight of ten Singapore IPOs were trading below their offer prices. Some had experienced declines of more than 50%.

This suggests that a substantial proportion of the newly listed companies in that assessment had failed to preserve their IPO valuations. However, the finding requires several qualifications.

First, the eight-of-ten figure describes the number of companies trading below their issue prices, not the average percentage loss across all IPOs. Second, it does not establish the total amount of shareholder wealth lost. Third, the reported performance reflects the market prices observed at the time of the assessment. Those prices may subsequently change.

Finally, without a fully reconciled list of the ten securities and their observation dates, the statistic should be treated as a published market assessment rather than an independently reconstructed SGX-wide performance index.

Even with those limitations, the broader concern is supported by earlier reporting. In September, Singapore Management University economist Goh Jing Rong told Channel NewsAsia that Singapore’s 2026 IPOs had not demonstrated a sustained post-debut rally. He identified weak aftermarket performance as a potential deterrent to future issuers.

The issue matters because a successful IPO market depends on confidence from both companies seeking capital and investors willing to provide it.

Why Strong IPO Demand May Not Translate Into Returns

An IPO’s subscription figures can create considerable excitement before trading begins. A heavily subscribed offering may suggest that investors are eager to acquire shares. However, oversubscription is not a reliable indicator of future performance.

Investors apply for IPO shares for different reasons. Some intend to hold the investment over several years. Others seek a short-term trading gain after the company begins trading.

Once shares become available on the secondary market, the price depends on actual buying and selling demand. Investors who received allocations may decide to sell. Other market participants may be unwilling to purchase the shares at the IPO valuation. Broader market conditions can also influence trading.

This means that even a well-publicised listing can fall below its offer price.

For Singapore, the challenge is particularly relevant because the exchange is attempting to attract a wider range of businesses. Investors accustomed to banks, property trusts and dividend-paying companies may assess emerging technology and healthcare businesses differently.

These companies can have greater growth potential, but they may also involve different financial and operational risks. A successful listing strategy must therefore consider whether the investor base understands the businesses being brought to market.

UltraGreen.ai Highlights the Risks of New-Economy Listings

One example of Singapore’s challenge is medical technology company UltraGreen.ai.

The company listed on SGX’s Mainboard in December 2025 through a US$400 million IPO. Its listing was regarded as an important development because it represented one of Singapore’s largest non-real estate investment trust offerings in several years.

UltraGreen.ai’s shares began trading at US$1.45. However, by 31 August 2026, the stock was trading at approximately US$0.685, a decline of more than 50% from its initial trading price.

The Straits Times reported that the decline was partly associated with concerns about competition in the company’s principal product market. UltraGreen.ai’s business involves indocyanine green dye used in medical procedures. The approval of a competing product by the US Food and Drug Administration raised questions about the company’s future competitive position.

The example demonstrates why investors must assess industry-specific risks rather than relying solely on a company’s growth narrative. Medical technology businesses may face regulatory, commercial and competitive developments that differ substantially from those affecting established banks or property companies.

However, UltraGreen.ai listed in 2025 and should not be counted as one of Singapore’s 2026 IPOs. Its experience is relevant as a broader illustration of the challenges involved in attracting new-economy companies to SGX.

MAS Introduces S$5 Billion Equity Market Development Programme

Singapore’s authorities have introduced measures intended to strengthen the local equities ecosystem.

Among the most significant is the Monetary Authority of Singapore’s Equity Market Development Programme. The programme was launched with S$5 billion to support investment in Singapore-listed equities through selected fund managers.

The initiative aims to strengthen liquidity, broaden market participation and improve the investment environment for listed companies.

Greater liquidity can make a stock market more attractive to both issuers and investors. For companies, an active secondary market may support more effective price discovery and access to capital. For investors, deeper trading activity can make it easier to buy or sell shares without substantially affecting market prices.

However, additional investment capital does not automatically guarantee positive returns. Fund managers must still evaluate the financial quality and valuation of the companies in which they invest.

The effectiveness of the programme should therefore be assessed through indicators such as trading activity, market depth, investor participation and sustainable company performance. The programme represents an important intervention, but it cannot substitute for the underlying investment merits of listed businesses.

Programme timing: this article retains the S$5 billion launch figure used in the preceding research. MAS subsequently announced that the programme had been expanded to S$6.5 billion in 2026. The source list includes both the launch measure and the later update.

SGX–Nasdaq Partnership Could Expand International Opportunities

Singapore is also pursuing closer connections with international capital markets.

One major initiative is the SGX–Nasdaq Global Listing Board, a dual-listing framework intended to simplify the process for eligible companies seeking to list in both Singapore and the United States.

By reducing duplicated documentation and facilitating access to two markets, the initiative could make Singapore more attractive to companies with international operations. For Southeast Asian businesses, the potential appeal lies in combining regional investor recognition with access to the much larger US capital market.

However, the practical benefits will depend on eligibility requirements, implementation and investor participation. A dual listing does not automatically create trading liquidity or increase a company’s valuation.

It also introduces additional considerations involving regulatory compliance, investor communications and market expectations. Companies must determine whether the benefits justify the costs and responsibilities associated with maintaining listings in multiple jurisdictions.

For SGX, the partnership represents an effort to differentiate Singapore from other regional exchanges rather than compete exclusively through domestic IPO volume.

New Listing Rules and Trading Reforms Aim to Improve Access

Singapore’s market-reform programme extends beyond direct investment support.

Authorities have also introduced measures intended to streamline listing processes and improve market accessibility. These include changes to listing regulations and adjustments to board-lot sizes for certain higher-priced securities.

From 5 October 2026, the standard board lot for eligible instruments priced above S$10 and up to S$100 was reduced from 100 units to 10 units. The change lowers the minimum transaction value for affected securities and may make higher-priced stocks more accessible to retail investors.

However, reducing board-lot sizes does not alter a company’s underlying valuation or financial prospects. It primarily affects the size of transactions investors can undertake. The measure should therefore be viewed as a market-access improvement rather than a direct solution to weak IPO performance.

Other reforms aim to reduce administrative friction for companies considering a listing. Bringing more of the Mainboard and Global Listing Board review process under SGX RegCo is intended to provide a clearer single touchpoint and a more predictable review timetable.

These initiatives may improve Singapore’s appeal as a listing destination, but faster procedures cannot replace due diligence or turn an unattractive valuation into an attractive investment. Market quality depends on the issuers that enter, the information available to investors and the discipline applied when shares are priced.

What Singapore’s Reforms Can — and Cannot — Solve

Singapore’s reform agenda addresses several genuine obstacles: limited liquidity outside large-cap stocks, high minimum transaction values for expensive shares, a fragmented listing process and the need to connect regional issuers with deeper pools of capital.

These measures can help improve the conditions in which a public market operates. They can encourage research coverage, widen participation and reduce friction for issuers and investors.

They cannot guarantee that every IPO will trade above its offer price. Nor should that be the objective of a functioning market. Share prices must be allowed to respond to company performance, valuation, new information and changing economic conditions.

The more useful test is whether Singapore develops a market in which good businesses can raise capital at credible valuations, investors receive sufficient information to evaluate risk, trading remains reasonably liquid and weak performance does not become the dominant experience of each new cohort.

What Investors Should Examine Before Buying an IPO

Subscription rates and first-day price movements can attract attention, but they should not replace analysis.

Investors should examine the issuer’s financial record, cash generation, debt, competitive position, use of proceeds and assumptions behind its growth forecasts. They should also compare the offer valuation with listed peers and consider whether cornerstone or controlling shareholders face lock-up periods that may affect the future supply of shares.

The structure of the offer also matters. Proceeds from newly issued shares support the company, while the sale of existing shares primarily allows current owners to realise part of their investment. Neither structure is inherently improper, but investors should understand where their money is going.

Finally, sector-specific risks require attention. A healthcare technology company, property trust, industrial business and financial institution should not be assessed through an identical lens.

Outlook: The Next Test Is After the Listing Ceremony

Singapore’s IPO market entered the final months of 2026 with greater momentum than it had shown in recent years. The reform programme, renewed deal flow and international initiatives provide a foundation for further development.

Yet listing-day activity is only the beginning. The quality of the companies entering the market, the reasonableness of their offer valuations and their ability to meet public-market expectations will determine whether the revival is sustainable.

Authorities can improve infrastructure and reduce friction. Exchanges can attract issuers and expand access. Fund managers and analysts can deepen research and liquidity. The final investment outcome, however, depends on the businesses themselves and the price investors pay.

Singapore has shown that it can raise substantial capital from relatively few IPOs. Its next challenge is to show that more of those listings can build confidence after trading begins.

Author